CBD in Switzerland

Do the Novel Food regulations in Europe affect your business?

CBD as a Novel Food: the future for edibles in Europe

This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.

Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.

This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.

Visit report

Free sample available